NCT03256253View on ClinicalTrials.gov

Pregabalin as Treatment for Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2020

Conditions
Alcohol Use Disorder
Interventions
DRUG

Pregabalin

pregabalin up to 600 mg/day

Trial Locations (1)

10019

Columbia Univeristy-STARS, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT03256253 - Pregabalin as Treatment for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter